A Clinical Trial Comparing the Performance of the JACTAX LD DES With the TAXUS Liberte DES.
Phase of Trial: Phase III
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Sponsors Boston Scientific Corporation; Labcoat
- 05 Aug 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 05 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Oct 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History